Staphylococcal superantigen super-domains in immune evasion

Critical Reviews in Immunology

Volumn 30, Issue 2, 2010, Pages 149-165

  Langley, Ries ^a   Patel, Deepa ^a   Jackson, Nicola ^a   Clow, Fiona ^a   Fraser, John D ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Complement; Innate immunity; SSL; Staphylococcus; Superantigen; Virulence

Indexed keywords

CHEMOTAXIS INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; VIRULENCE FACTOR;

ANTIGEN EXPRESSION; BACTERIAL VIRULENCE; HUMAN; IMMUNOMODULATION; INFECTION RESISTANCE; INNATE IMMUNITY; MACROPHAGE ACTIVATION; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE ACTIVATION; ANIMAL; CHEMISTRY; GENETICS; IMMUNE EVASION; IMMUNOLOGY; PROTEIN TERTIARY STRUCTURE;

ANIMALS; HUMANS; IMMUNE EVASION; PROTEIN STRUCTURE, TERTIARY; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS;

EID: 77950998544     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevimmunol.v30.i2.40     Document Type: Review

References (76)

1. Lowy FD. Staphylococcus aureus infection. N Engl J Med 1998;339:520-532
2. van Belkum A, Melles DC, Nouwen J, van Leeuwen WB, van Wamel W, Vos MC, Wertheim HF, Verbrugh HA. Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus. Infect Genet Evol. 2009 Jan;9(1):32-47
3. van Belkum A, Verkaik NJ, de Vogel CP, Boelens HA, Verveer J, Nouwen JL, Verbrugh HA, Wertheim HF. Reclassifcation of Staphylococcus aureus nasal carriage types. J Infect Dis. 2009 Jun 15;199(12):1820-1826 (Pubitemid 41688980)
4. Verkaik NJ, de Vogel CP, Boelens HA, Grumann D, Hoogenboezem T, Vink C, Hooijkaas H, Foster TJ, Verbrugh HA, van Belkum A, van Wamel WJ. Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus. J Infect Dis. 2009 Mar 1;199(5):625-632
5. Foster TJ. Immune evasion by staphylococci. Nat Rev Microbiol. 2005 Dec;3(12):948-958
6. Gill SR, Fouts DE, Archer GL, Mongodin EF, Deboy RT, Ravel J, Paulsen I T, Kolonay JF, Brinkac L, Beanan M, Dodson RJ, Daugherty SC, Madupu R, Angiuoli SV, Durkin AS, Haft DH, Vamathevan J, Khouri H, Utterback T, Lee C, Dimitrov G, Jiang L, Qin H, Weidman J, Tran K, Kang K, Hance IR, Nelson KE, Fraser CM.Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a bioflm-producing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol. 2005 Apr;187(7):2426-2438 (Pubitemid 40389140)
7. Rooijakkers SH, van Kessel KP, van Strijp JA. Staphylococcal innate immune evasion. Trends Microbiol. 2005 Dec;13(12):596-601
8. Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Kobayashi I, Cui L, Oguchi A, Aoki K, Nagai Y, Lian J, Ito T, Kanamori M, Matsumaru H, Maruyama A, Murakami H, Hosoyama A, Mizutani-Ui Y, Takahashi NK, Sawano T, Inoue R, Kaito C, Sekimizu K, Hirakawa H, Kuhara S, Goto S, Yabuzaki J, Kanehisa M, Yamashita A, Oshima K, Furuya K, Yoshino C, Shiba T, Hattori M, Ogasawara N, Hayashi H, Hiramatsu K. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet. 2001 Apr 21;357(9264):1225-1240 (Pubitemid 32539050)
9. Lambris JD, Ricklin D, Geisbrecht BV. Complement evasion by human pathogens. Nat Rev Microbiol. 2008 Feb;6(2):132-142
10. Lindsay JA, Holden MT. Understanding the rise of the superbug: investigation of the evolution and genomic variation of Staphylococcus aureus. Funct Integr Genomics. 2006 Jul;6(3):186-201
11. Lehrer RI. Primate defensins. Nat Rev Microbiol. 2004 Sep;2(9):727-738
12. Mölne L, Verdrengh M, Tarkowski A. Role of neutrophil leukocytes in cutaneous infection caused by Staphylococcus aureus. Infect Immun. 2000 Nov;68(11):6162-6167
13. Massey RC, Horsburgh MJ, Lina G, Höök M, Recker M. Te evolution and maintenance of virulence in Staphylococcus aureus: a role for host-to-host transmission? Nat Rev Microbiol. 2006 Dec;4(12):953-958
14. Houghton AM, Hartzell WO, Robbins CS, Gomis-Rüth FX, Shapiro SD. Macrophage elastase kills bacteria within murine macrophages. Nature. 2009 Jul 30;460(7255):637-641
15. Corbin BD, Seeley EH, Raab A, Feldmann J, Miller MR, Torres VJ, Anderson KL, Dattilo BM, Dunman PM, Gerads R, Caprioli RM, Nacken W, Chazin WJ, Skaar EP. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science. 2008 Feb 15;319(5865):962-965
16. Liu GY, Essex A, Buchanan J T, Datta V, Hofman HM, Bastian JF, Fierer J, Nizet V. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med. 2005 Jul 18;202(2):209-215
17. Bergdoll MS. Enterotoxins. In: Easom CSF, Adlam C, eds. Staphyloccoi and staphylococcal infections. New York: Academic Press, 1983
18. Fraser J, Arcus V, Kong P, Baker E, Proft T. Superantigens-powerful modifers of the immune system. Mol Med Today. 2000 Mar;6(3):125-132
19. Fraser JD, Kotb M, eds. Superantigens: molecular basis and role in human disease. Vol.1. New York: ASM Press, New York; 2006
20. Li H, Llera A, Mariuzza RA. Structure-function studies of T-cell receptor-superantigen interactions. Immunol Rev. 1998 Jun;163:177-186
21. Tomas DY, Jarraud S, Lemercier B, Cozon G, Echasserieau K, Etienne J, Gougeon ML, Lina G, Vandenesch F. Staphylococcal enterotoxin-like toxins U2 and V, two new staphylococcal superantigens arising from recombination within the entero-toxin gene cluster. Infect Immun. 2006 Aug;74(8): 4724-4734
22. Tomas D, Chou S, Dauwalder O, Lina G. Diversity in Staphylococcus aureus enterotoxins. Chem Immunol Allergy. 2007;93:24-41
23. Ono HK, Omoe K, Imanishi K, Iwakabe Y, Hu DL, Kato H, Saito N, Nakane A, Uchiyama T, Shinagawa K. Identifcation and characterization of two novel staphylococcal enterotoxins, types S and T. Infect Immun. 2008 Nov;76(11):4999-5005
24. Hudson KR, Robinson H, Fraser JD. Two adjacent residues in staphylococcal enterotoxins A and E determine T cell receptor V beta specifcity. J Exp Med. 1993 Jan 1;177(1):175-184
25. Proft T, Mofatt SL, Weller KD, Paterson A, Martin D, Fraser JD. Te streptococcal superantigen SMEZ exhibits wide allelic variation, mosaic structure, and signifcant antigenic variation. J Exp Med. 2000 May 15;191(10):1765-1776 (Pubitemid 30331573)
26. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, Nagai Y, Iwama N, Asano K, Naimi T, Kuroda H, Cui L, Yamamoto K, Hiramatsu K. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 2002 May 25;359(9320):1819-1827 (Pubitemid 34607058)
27. Ruzin A, Lindsay J, Novick RP. Molecular genetics of SaPI1-a mobile pathogenicity island in Staphylococcus aureus. Mol Microbiol. 2001 Jul;41(2):365-377 (Pubitemid 32730537)
28. Williams RJ, Ward JM, Henderson B, Poole S, OHara BP, Wilson M, Nair SP. Identifcation of a novel gene cluster encoding staphylococcal exotoxin-like proteins: characterization of the prototypic gene and its protein product, SET1. I Infect Immun. 2000 Aug;68(8): 4407-4415 (Pubitemid 30497705)
29. Lina G, Bohach GA, Nair SP, Hiramatsu K, Jouvin-Marche E, Mariuzza R; International Nomenclature Committee for Staphylococcal Superantigens. Standard nomenclature for the superantigens expressed by Staphylococcus. J Infect Dis. 2004 Jun 15;189(12): 2334-2336
30. Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Chi YI, Staufacher C, Strominger JL, Wiley DC. Tree-dimensional structure of a human class II histocompatibility molecule complexed with superan-tigen. Nature. 1994 Apr 21;368(6473):711-718 (Pubitemid 24153410)
31. Kim J, Urban RG, Strominger JL, Wiley DC. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science. 1994 Dec 16;266(5192):1870-1874
32. Jongerius I, Köhl J, Pandey MK, Ruyken M, van Kessel KP, van Strijp JA, Rooijakkers SH. Staphylococcal complement evasion by various convertase-block-ing molecules. J Exp Med. 2007 Oct 1;204(10): 2461-2471 (Pubitemid 47529330)
33. Schad EM, Zaitseva I, Zaitsev VN, Dohlsten M, Kalland T, Schlievert PM, Ohlendorf DH, Svensson LA. Crystal structure of the superantigen staphy-lococcal enterotoxin type A. EMBO J. 1995 Jul 17;14(14):3292-3301
34. Swaminathan S, Furey W, Pletcher J, Sax M. Crystal structure of staphylococcal enterotoxin B, a superan-tigen. Nature. 1992 Oct 29;359(6398):801-806
35. Papageorgiou AC, Acharya KR, Shapiro R, Passalacqua EF, Brehm RD, Tranter HS. Crystal structure of the superantigen enterotoxin C2 from Staphylococcus aureus reveals a zinc-binding site. Structure. 1995 Aug 15;3(8):769-779
36. Fields BA, Malchiodi EL, Li H, Ysern X, Staufacher CV, Schlievert PM, Karjalainen K, Mariuzza RA. Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature. 1996 Nov 14;384(6605):188-192 (Pubitemid 26386477)
37. Sundström M, Abrahmsén L, Antonsson P, Mehindate K, Mourad W, Dohlsten M. Te crystal structure of staphylococcal enterotoxin type D reveals Zn2+-mediated homodimerization. EMBO J. 1996 Dec 16;15(24):6832-6840 (Pubitemid 27023253)
38. Fernández MM, Bhattacharya S, De Marzi MC, Brown PH, Kerzic M, Schuck P, Mariuzza RA, Malchiodi EL. Superantigen natural afnity maturation revealed by the crystal structure of staphylococcal enterotoxin G and its binding to T-cell receptor Vbeta8.2. Proteins. 2007 Jul 1;68(1):389-402
39. Hâkansson M, Petersson K, Nilsson H, Forsberg G, Björk P, Antonsson P, Svensson LA. Te crystal structure of staphylococcal enterotoxin H: implications for binding properties to MHC class II and TcR molecules. J Mol Biol. 2000 Sep 22;302(3):527-537
40. Fernández MM, Guan R, Swaminathan CP, Malchiodi EL, Mariuzza RA. Crystal structure of staphylococcal enterotoxin I (SEI) in complex with a human major histocompatibility complex class II molecule. J Biol Chem. 2006 Sep 1;281(35):25356-25364
41. Günther S, Varma AK, Moza B, Kasper KJ, Wyatt AW, Zhu P, Rahman AK, Li Y, Mariuzza RA, McCormick JK, Sundberg EJ. A novel loop domain in superantigens extends their T cell receptor recognition site. J Mol Biol. 2007 Aug 3;371(1):210-221
42. Acharya KR, Passalacqua EF, Jones EY, Harlos K, Stuart DI, Brehm RD, Tranter HS. Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1. Nature. 1994 Jan 6;367(6458):94-97
43. Papageorgiou AC, Collins CM, Gutman DM, Kline JB, OBrien SM, Tranter HS, Acharya KR. Structural basis for the recognition of superantigen streptococ-cal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors. EMBO J. 1999 Jan 4;18(1):9-21
44. Roussel A, Anderson BF, Baker HM, Fraser JD, Baker EN. Crystal structure of the streptococcal superantigen SPE-C: dimerization and zinc binding suggest a novel mode of interaction with MHC class II molecules. Nat Struct Biol. 1997 Aug;4(8):635-643
45. Arcus VL, Proft T, Sigrell JA, Baker HM, Fraser JD, Baker EN. Conservation and variation in superanti-gen structure and activity highlighted by the three-dimensional structures of two new superantigens from Streptococcus pyogenes. J Mol Biol. 2000 May 26;299(1):157-168
46. Saarinen S, Kato H, Uchiyama T, Miyoshi-Akiyama T, Papageorgiou AC. Crystal structure of Streptococcus dysgalactiae-derived mitogen reveals a zinc-binding site and alterations in TcR binding. J Mol Biol. 2007 Nov 9;373(5):1089-1097
47. Al-Shangiti AM, Naylor CE, Nair SP, Briggs DC, Henderson B, Chain BM. Structural relationships and cellular tropism of staphylococcal superantigen-like proteins. Infect Immun. 2004 Jul;72(7):4261-4270
48. Arcus VL, Langley R, Proft T, Fraser JD, Baker EN. Te three-dimensional structure of a superantigen-like protein, SET3, from a pathogenicity island of the Staphylococcus aureus genome. J Biol Chem. 2002 Aug 30;277(35):32274-32281
49. Chung MC, Wines BD, Baker H, Langley RJ, Baker EN, Fraser JD. Te crystal structure of staphylococ-cal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition. Mol Microbiol. 2007 Dec;66(6):1342-1355
50. Murzin AG. OB(oligonucleotide/oligosaccharide binding)-fold: common structural and functional solution for non-homologous sequences. EMBO J. 1993 Mar;12(3):861-867
51. Zhang C, Kim SH. Te anatomy of protein beta-sheet topology. J Mol Biol. 2000 Jun 16;299(4):1075-1089
52. Arcus V. OB-fold domains: a snapshot of the evolution of sequence, structure and function. Curr Opin Struct Biol. 2002 Dec;12(6):794-801
53. Langley R, Wines B, Willoughby N, Basu I, Proft T, Fraser JD. Te staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria. J Immunol. 2005 Mar 1;174(5):2926-2933
54. Ramsland PA, Willoughby N, Trist HM, Farrugia W, Hogarth PM, Fraser JD, Wines BD. Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1. Proc Natl Acad Sci USA. 2007 Sep 18;104(38):15051-15056
55. Baker HM, Basu I, Chung MC, Caradoc-Davies T, Fraser JD, Baker EN. Crystal structures of the staphy-lococcal toxin SSL5 in complex with sialyl Lewis X reveal a conserved binding site that shares common features with viral and bacterial sialic acid binding proteins. J Mol Biol. 2007 Dec 14;374(5):1298-1308
56. Bestebroer J, Poppelier MJ, Ulfman LH, Lenting PJ, Denis CV, van Kessel KP, van Strijp JA, de Haas CJ. Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling. Blood. 2007 Apr 1;109(7):2936-2943
57. Bestebroer J, van Kessel KP, Azouagh H, Walenkamp AM, Boer IG, Romijn RA, van Strijp JA, de Haas CJ. Staphylococcal SSL5 inhibits leukocyte activation by chemokines and anaphylatoxins. Blood. 2009 Jan 8;113(2):328-337
58. Novick RP. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol. 2003 Jun;48(6):1429-1449 (Pubitemid 36751052)
59. Grumann D, Scharf SS, Holtfreter S, Kohler C, Steil L, Engelmann S, Hecker M, Völker U, Bröker BM. Immune cell activation by enterotoxin gene cluster (egc)-encoded and non-egc superantigens from Staphylococcus aureus. J Immunol. 2008 Oct 1;181(7):5054-5061
60. Torres VJ, Stauff DL, Pishchany G, Bezbradica JS, Gordy LE, Iturregui J, Anderson KL, Dunman PM, Joyce S, Skaar EP. A Staphylococcus aureus regulatory system that responds to host heme and modulates virulence. Cell Host Microbe. 2007 Apr 19;1(2):109-119 (Pubitemid 46554913)
61. Skaar EP, Humayun M, Bae T, DeBord KL, Schneewind O. Iron-source preference of Staphylococcus aureus infections. Science. 2004 Sep 10;305(5690):1626-1628 (Pubitemid 39296358)
62. de Haas CJ, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJ, Heezius EC, Poppelier MJ, Van Kessel K P, van Strijp JA. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiin-fammatory agent. J Exp Med. 2004 Mar 1;199(5): 687-695 (Pubitemid 38316435)
63. Veldkamp KE, Heezius HC, Verhoef J, van Strijp JA, van Kessel KP. Modulation of neutrophil chemokine receptors by Staphylococcus aureus supernate. Infect Immun. 2000 Oct;68(10):5908-5913
64. Postma B, Poppelier MJ, van Galen JC, Prossnitz ER, van Strijp JA, de Haas CJ, van Kessel KP. Chemotaxis inhibitory protein of Staphylococcus aureus binds spe-cifcally to the C5a and formylated peptide receptor. J Immunol. 2004 Jun 1;172(11):6994-7001 (Pubitemid 38669140)
65. Haas PJ, de Haas CJ, Kleibeuker W, Poppelier MJ, van Kessel KP, Kruijtzer JA, Liskamp RM, van Strijp JA. N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor. J Immunol. 2004 Nov 1;173(9): 5704-5711 (Pubitemid 39392159)
66. McGavin MH, Krajewska-Pietrasik D, Rydén C, Höök M. Identifcation of a Staphylococcus aureus extracellular matrix-binding protein with broad specifcity. Infect Immun. 1993 Jun;61(6):2479-2485 (Pubitemid 23159238)
67. Palma M, Haggar A, Flock JI. Adherence of Staphylococcus aureus is enhanced by an endogenous secreted protein with broad binding activity. J Bacteriol. 1999 May;181(9):2840-2845 (Pubitemid 29211101)
68. Geisbrecht BV, Hamaoka BY, Perman B, Zemla A, Leahy DJ. Te crystal structures of EAP domains from Staphylococcus aureus reveal an unexpected homology to bacterial superantigens. J Biol Chem. 2005 Apr 29;280(17):17243- 17250 (Pubitemid 41389192)
69. Hussain M, Haggar A, Heilmann C, Peters G, Flock JI, Herrmann M. Insertional inactivation of Eap in Staphylococcus aureus strain Newman confers reduced staphylococcal binding to fbroblasts. Infect Immun. 2002 Jun;70(6):2933-2940 (Pubitemid 34564151)
70. Chavakis T, Hussain M, Kanse SM, Peters G, Bretzel RG, Flock JI, Herrmann M, Preissner KT. Staphylococcus aureus extracellular adherence protein serves as anti-infammatory factor by inhibiting the recruitment of host leukocytes. Nat Med. 2002 Jul;8(7):687-693 (Pubitemid 34778721)
71. Athanasopoulos AN, Economopoulou M, Orlova VV, Sobke A, Schneider D, Weber H, Augustin HG, Eming SA, Schubert U, Linn T, Nawroth PP, Hussain M, Hammes HP, Herrmann M, Preissner KT, Chavakis T. Te extracellular adherence protein (Eap) of Staphylococcus aureus inhibits wound healing by interfering with host defense and repair mechanisms. Blood. 2006 Apr 1;107(7):2720-2727
72. Rooijakkers SH, Ruyken M, Roos A, Daha MR, Presanis JS, Sim RB, van Wamel WJ, van Kessel KP, van Strijp JA. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol. 2005 Sep;6(9):920-927 (Pubitemid 43090447)
73. van Wamel WJ, Rooijakkers SH, Ruyken M, van Kessel KP, van Strijp JA. Te innate immune modulators staphylococcal complement inhibitor and chemot-axis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin- converting bacteriophages. J Bacteriol. 2006 Feb;188(4):1310-1315 (Pubitemid 43228664)
74. Rooijakkers SH, Wu J, Ruyken M, van Domselaar R, Planken KL, Tzekou A, Ricklin D, Lambris JD, Janssen BJ, van Strijp JA, Gros P. Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphy-lococcal inhibitor. Nat Immunol. 2009 Jul;10(7): 721-727
75. Guarda G, Dostert C, Staehli F, Cabalzar K, Castillo R, Tardivel A, Schneider P, Tschopp J. T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 infammasomes. Nature. 2009 Jul 9;460(7252):269-273
76. Laursen NS, Gordon N, Hermans S, Lorenz N, Jackson N, Wines B, Spillner E, Christensen JB, Jensen M, Fredslund F, Bjerre M, Sottrup-Jensen L, Fraser JD, Andersen GR. Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus. Proc Natl Acad Sci USA. 2010 Feb 23;107(8):3681-3686